A novel 18F-labeled two-helix scaffold protein for PET imaging of HER2-positive tumor

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 38, Issue 11, 2011, Pages 1977-1984

  Miao, Zheng ^a   Ren, Gang ^a   Jiang, Lei ^a   Liu, Hongguang ^a   Webster, Jack M ^b   Zhang, Rong ^b   Namavari, Mohammad ^c   Gambhir, Sanjiv S ^c   Syud, Faisal ^b   Cheng, Zhen ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GENERAL ELECTRIC COMPANY   (United States)

^c STANFORD CANCER INSTITUTE   (United States)

Author keywords

18F; Affibody; HER2; PET; Scaffold protein

Indexed keywords

AMINOOXY FUNCTIONALIZED TWO HELIX PEPTIDE FLUORINE 18; CYCLOPEPTIDE; DISULFIDE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FLUORINE 18; IODINE; SCAFFOLD PROTEIN; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; FLUORINE; PEPTIDE;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CELL TRANSPORT; DISULFIDE BOND; IMAGE QUALITY; MOUSE; NONHUMAN; OXIDATION KINETICS; PEPTIDE SYNTHESIS; POSITRON EMISSION TOMOGRAPHY; TISSUE SPECIFICITY; TUMOR; TUMOR LOCALIZATION; AMINO ACID SEQUENCE; ANIMAL; CELL TRANSFORMATION; CHEMISTRY; FEMALE; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; OVARY TUMOR; PATHOLOGY; PROTEIN SECONDARY STRUCTURE; RADIOCHEMISTRY; SCINTISCANNING; TUMOR CELL LINE;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; FLUORINE RADIOISOTOPES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MOLECULAR SEQUENCE DATA; OVARIAN NEOPLASMS; PEPTIDES; POSITRON-EMISSION TOMOGRAPHY; PROTEIN STRUCTURE, SECONDARY; RADIOCHEMISTRY; RECEPTOR, ERBB-2;

EID: 80255126827     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-011-1879-9     Document Type: Article

References (27)

1. EV Getmanova Y Chen L Bloom J Gokemeijer S Shamah V Warikoo, et al. 2006 Antagonists to human and mouse vascular endothelial growth factor receptor 2 generated by directed protein evolution in vitro Chem Biol 13 549 556 16720276 10.1016/j.chembiol.2005.12.009 1:CAS:528:DC%2BD28XkvVCqtb8%3D (Pubitemid 43744513)
2. A Jonsson H Wållberg N Herne S Ståhl FY Frejd 2009 Generation of tumour-necrosis-factor-alpha-specific affibody molecules capable of blocking receptor binding in vitro Biotechnol Appl Biochem 54 93 103 19545237 10.1042/BA20090085 1:CAS:528:DC%2BD1MXpvF2iu7o%3D
3. RH Kimura AM Levin FV Cochran JR Cochran 2009 Engineered cystine knot peptides that bind alphavbeta3, alphavbeta5, and alpha5beta1 integrins with low-nanomolar affinity Proteins 77 359 369 19452550 10.1002/prot.22441 1:CAS:528:DC%2BD1MXhtV2lt7fO
4. A Orlova M Magnusson TL Eriksson M Nilsson B Larsson I Höidén-Guthenberg, et al. 2006 Tumor imaging using a picomolar affinity HER2 binding affibody molecule Cancer Res 66 4339 4348 16618759 10.1158/0008-5472.CAN-05-3521 1:CAS:528:DC%2BD28XjsFSltbs%3D
5. AP Silverman AM Levin JL Lahti JR Cochran 2009 Engineered cystine-knot peptides that bind alpha(v)beta(3) integrin with antibody-like affinities J Mol Biol 385 1064 1075 19038268 10.1016/j.jmb.2008.11.004 1:CAS:528: DC%2BD1MXntFegug%3D%3D
6. DS Gill NK Damle 2006 Biopharmaceutical drug discovery using novel protein scaffolds Curr Opin Biotechnol 17 653 658 17055245 10.1016/j.copbio. 2006.10.003 1:CAS:528:DC%2BD28Xht1eqs73N (Pubitemid 44802987)
7. A Orlova V Tolmachev R Pehrson M Lindborg T Tran M Sandström, et al. 2007 Synthetic affibody molecules: a novel class of affinity ligands for molecular imaging of HER2-expressing malignant tumors Cancer Res 67 2178 2186 17332348 10.1158/0008-5472.CAN-06-2887 1:CAS:528:DC%2BD2sXitlSjs78%3D (Pubitemid 46424237)
8. F Meric-Bernstam MC Hung 2006 Advances in targeting human epidermal growth factor receptor-2 signaling for cancer therapy Clin Cancer Res 12 6326 6330 17085641 10.1158/1078-0432.CCR-06-1732 1:CAS:528:DC%2BD28XhtFKitLbE (Pubitemid 44799700)
9. B Leader QJ Baca DE Golan 2008 Protein therapeutics: a summary and pharmacological classification Nat Rev Drug Discov 7 21 39 18097458 10.1038/nrd2399 1:CAS:528:DC%2BD1cXht1ygtQ%3D%3D
10. D Artemov N Mori R Ravi ZM Bhujwalla 2003 Magnetic resonance molecular imaging of the HER-2/neu receptor Cancer Res 63 2723 2727 12782573 1:CAS:528:DC%2BD3sXkt1ajur8%3D (Pubitemid 36667139)
11. I Hilger Y Leistner A Berndt C Fritsche KM Haas H Kosmehl, et al. 2004 Near-infrared fluorescence imaging of HER-2 protein over-expression in tumour cells Eur Radiol 14 1124 1129 15118831 10.1007/s00330-004-2257-9 (Pubitemid 38787258)
12. T Engfeldt A Orlova T Tran A Bruskin C Widström AE Karlström, et al. 2007 Imaging of HER2-expressing tumours using a synthetic Affibody molecule containing the 99mTc-chelating mercaptoacetyl-glycyl-glycyl-glycyl (MAG3) sequence Eur J Nucl Med Mol Imaging 34 722 733 17146656 10.1007/s00259-006-0266-4 1:CAS:528:DC%2BD2sXks1agsLY%3D (Pubitemid 46669355)
13. FY Nilsson V Tolmachev 2007 Affibody molecules: new protein domains for molecular imaging and targeted tumor therapy Curr Opin Drug Discov Devel 10 167 175 17436552 1:CAS:528:DC%2BD2sXktVOntrw%3D (Pubitemid 46438646)
14. AC Steffen A Orlova M Wikman FY Nilsson S Ståhl GP Adams, et al. 2006 Affibody-mediated tumour targeting of HER-2 expressing xenografts in mice Eur J Nucl Med Mol Imaging 33 631 638 16538504 10.1007/s00259-005-0012-3 1:CAS:528:DC%2BD28Xlt1KqsLc%3D (Pubitemid 43846754)
15. Z Cheng OP De Jesus DJ Kramer A De JM Webster O Gheysens, et al. 2009 64Cu-labeled affibody molecules for imaging of HER2 expressing tumors Mol Imaging Biol 12 316 324 19779897 10.1007/s11307-009-0256-6
16. C Eigenbrot M Ultsch A Dubnovitsky L Abrahmsén T Härd 2010 Structural basis for high-affinity HER2 receptor binding by an engineered protein Proc Natl Acad Sci USA 107 15039 15044 20696930 10.1073/pnas.1005025107 1:CAS:528:DC%2BC3cXhtFSmt7vK
17. JM Webster R Zhang SS Gambhir Z Cheng FA Syud 2009 Engineered two-helix small proteins for molecular recognition Chembiochem 10 1293 1296 19422008 10.1002/cbic.200900062 1:CAS:528:DC%2BD1MXmtlOlsr0%3D
18. G Ren R Zhang Z Liu JM Webster Z Miao SS Gambhir, et al. 2009 A 2-helix small protein labeled with 68Ga for PET imaging of HER2 expression J Nucl Med 50 1492 1499 19690041 10.2967/jnumed.109.064287 1:CAS:528:DC%2BD1MXhtFOrtbvJ
19. Z Cheng OP De Jesus M Namavari A De J Levi JM Webster, et al. 2008 Small-animal PET imaging of human epidermal growth factor receptor type 2 expression with site-specific 18F-labeled protein scaffold molecules J Nucl Med 49 804 813 18413392 10.2967/jnumed.107.047381 1:CAS:528:DC%2BD1cXmvVSju7o%3D (Pubitemid 351717547)
20. M Namavari O Padilla De Jesus Z Cheng A De E Kovacs J Levi, et al. 2008 Direct site-specific radiolabeling of an Affibody protein with 4-[18F]fluorobenzaldehyde via oxime chemistry Mol Imaging Biol 10 177 181 18481153 10.1007/s11307-008-0142-7
21. Z Miao G Ren H Liu L Jiang Z Cheng 2010 Small-animal PET imaging of human epidermal growth factor receptor positive tumor with a 64Cu labeled affibody protein Bioconjug Chem 21 947 954 20402512 10.1021/bc900515p 1:CAS:528:DC%2BC3cXkvVKrtb8%3D
22. L Jiang RH Kimura Z Miao AP Silverman G Ren H Liu, et al. 2010 Evaluation of a (64)Cu-labeled cystine-knot peptide based on agouti-related protein for PET of tumors expressing alphavbeta3 integrin J Nucl Med 51 251 258 20124048 10.2967/jnumed.109.069831
23. PJ Perik MN Lub-De Hooge JA Gietema WT van der Graaf MA de Korte S Jonkman, et al. 2006 Indium-111-labeled trastuzumab scintigraphy in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer J Clin Oncol 24 2276 2282 16710024 10.1200/JCO.2005.03.8448 1:CAS:528: DC%2BD28XlvV2ksLc%3D (Pubitemid 46630657)
24. W Tai R Mahato K Cheng 2010 The role of HER2 in cancer therapy and targeted drug delivery J Control Release 146 264 275 20385184 10.1016/j.jconrel.2010.04.009 1:CAS:528:DC%2BC3cXhtFWgt7zL
25. HS Gill JN Tinianow A Ogasawara JE Flores AN Vanderbilt H Raab, et al. 2009 A modular platform for the rapid site-specific radiolabeling of proteins with 18F exemplified by quantitative positron emission tomography of human epidermal growth factor receptor 2 J Med Chem 52 5816 5825 19736996 10.1021/jm900420c 1:CAS:528:DC%2BD1MXhtFajsr%2FO
26. G Kramer-Marek DO Kiesewetter L Martiniova E Jagoda SB Lee J Capala 2008 [18F]FBEM-Z(HER2:342)-Affibody molecule-a new molecular tracer for in vivo monitoring of HER2 expression by positron emission tomography Eur J Nucl Med Mol Imaging 35 1008 1018 18157531 10.1007/s00259-007-0658-0 1:CAS:528: DC%2BD1cXkvVyjuro%3D
27. RP Baum V Prasad D Müller C Schuchardt A Orlova A Wennborg, et al. 2010 Molecular imaging of HER2-expressing malignant tumors in breast cancer patients using synthetic 111In- or 68Ga-labeled affibody molecules J Nucl Med 51 892 897 20484419 10.2967/jnumed.109.073239